PerkinElmer's role in the historic Cassini spacecraft mission to Saturn.
New research by PerkinElmer confirms that PD-L1 protein expression levels in human breast cancer cells can be quickly and accurately assessed directly with the AlphaLISA human PD-L1 assay.
The Australian Institute of Marine Science (AIMS) is helping to sustain and restore damage to ecosystems due to a changing climate and microplastics contamination in the Great Barrier Reef.
North York General Hospital researchers have developed an Enhanced First Trimester Screen that is faster, less costly, but just as accurate as the standard Integrated Prenatal Screening protocol in detecting the risk for Down syndrome and Trisomy 18. The new test was developed with the help of PerkinElmer and is now in use in Ontario, Canada.
Eurofins Scientific worked with PerkinElmer and Environmental Sciences, Inc. to optimizes production analysis of a wide range of samples from food and liquids to pharmaceuticals built on PerkinElmer’s NexION ICP-MS and the intelligent autosampling of ESI’s SC-FAST innovation.
Using a PerkinElmer Opera Phenix Imaging System and proprietary analytic algorithms, a team of Austrian scientists developed Pharmacoscopy, a method to rapidly screen existing drugs for potential use in cancer immunotherapy.
An overview of Juniper Analytics and its quest to become a certified cannabis testing lab in Oregon with the help of PerkinElmer and the QSight® Triple Quad LC/MS/MS.
Scientist undertakes historical assessment of the Tennessee River’s water quality with the help of PerkinElmer.
Pharmaceutical services company Aptuit used two different methods to arrive at the same conclusion: PerkinElmer's NexION® ICP-MS is the best analytical instrument on the market.
Cord blood stem cells saved at birth have offered hope to families faced with life-changing medical conditions once thought untreatable, such as cerebral palsy and autism.